SAN DIEGO, CA - (January 30, 2001) - Privately held Structural Bioinformatics, Inc. (SBI) today announced that James A. Myer, Ph.D. has joined the Company's Board of Directors.

Dr. Myer was the founder and has served as the President and Chairman of the Board of Photon Research Associates, Inc. (PRA) since 1976. Under his guidance PRA has grown to its current staff of 150 persons in six locations across the United States. PRA is a leading provider of physics-based modeling, simulation and analysis products for government and commercial markets, providing expert research services and software tools for electro-optical sensor design; aircraft and satellite simulation; mission planning and analysis; algorithm development and data warehousing.

Prior to founding PRA, Dr. Myer held a number of key management positions at SAIC and at the Avco Everett Research Laboratory where, in addition to other responsibilities, he managed the AMOS Optical Site at the Mt. Haleakala summit on Maui, Hawaii. Dr. Myer was instrumental in the formation of four PRA subsidiaries: Moldyn, Inc., recently acquired by SBI; Photon Simulations, Inc. and PRA Simulations, Inc., both of which were ultimately acquired by Computer Associates; as well as EarthScan Network, Inc. Dr. Myer currently serves on the Board of four innovative companies in the realm of high technology computational tools. In 1972, Dr. Myer was awarded a patent for the Tunable Laser, just one highlight of his work at the forefront of technical innovation. He currently serves on the Army Science Board and is a scientific advisor to a number of governmental policy making organizations.

"With the recent acquisition of Moldyn, Inc. by SBI, we are extremely privileged to have Dr. Myer join us as a member of our Board," said Dr. Edward T. Maggio, Chairman, President and Chief Executive Officer of SBI. "Dr. Myer's vast experience will be invaluable in the integration and elaboration of Moldyn and PRA technologies into the SBI family of computational tools and protocols."

About Structural Bioinformatics, Inc.

SBI is a world leader in computational proteomics -- the large-scale generation and use of protein structure and protein structural information. The Company has developed advanced technologies to generate highly refined 3-dimensional structural models of proteins from primary genetic information and commercializes these technologies through its structural database products and through drug discovery collaborations with leading pharmaceutical companies. SBI has offices and research facilities in San Diego, CA; Cambridge, MA; and Hørsholm, Denmark. More information about SBI can be found on the company's website at: http://www.strubix.com.